Adverse events in older patients undergoing ERCP: a systematic review and meta-analysis
Authors:
Open Access
- 7 March 2014
- journal article
- review article
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 2 (01) , E28-E36
Abstract
Background and study aims: Biliary and pancreatic diseases are common in the elderly; however, few studies have addressed the occurrence of adverse events in elderly patients undergoing endoscopic retrograde cholangiopancreatography (ERCP). Our objective was to determine the incidence rates of specific adverse events in this group and calculate incidence rate ratios (IRRs) for selected comparison groups. Patients and methods: Bibliographical searches were conducted in Medline, EMBASE, and Cochrane library databases. The studies included documented the incidence of adverse events (perforation, pancreatitis, bleeding, cholangitis, cardiopulmonary adverse events, mortality) in patients aged ≥ 65 who underwent ERCP. Pooled incidence rates were calculated for each reported adverse event and IRRs were determined for available comparison groups. A parallel analysis was performed in patients aged ≥ 80 and ≥ 90. Results: Our literature search yielded 7429 articles, of which 69 studies met our inclusion criteria. Pooled incidence rates for adverse events (per 1000 ERCPs) in patients aged ≥ 65 were as follows: perforation 3.8 (95 %CI 1.8 – 7.0), pancreatitis 13.1 (95 %CI 11.0 – 15.5), bleeding 7.7 (95 %CI 5.7 – 10.1), cholangitis 16.1 (95 %CI 11.7 – 21.7), cardiopulmonary events 3.7 (95 %CI 1.5 – 7.6), and death 7.1 (95 %CI 5.2 – 9.4). Patients ≥ 65 had lower rates of pancreatitis (IRR 0.3, 95 %CI 0.3 – 0.4) compared with younger patients. Octogenarians had higher rates of death (IRR 2.4, 95 %CI 1.3 – 4.5) compared with younger patients, whereas nonagenarians had increased rates of bleeding (IRR 2.4, 95 %CI 1.1 – 5.2), cardiopulmonary events (IRR 3.7, 95 %CI 1.0 – 13.9), and death (IRR 3.8, 95 %CI 1.0 – 14.4). Conclusions ERCP appears to be safe in elderly patients, except in the very elderly who are at higher risk of some adverse events. These data on adverse event rates can help to inform clinical decision-making, the consent process, and comparative effectiveness analyses. * Lukejohn W. Day, MD and Lisa Lin, MD are the first authors.Keywords
This publication has 86 references indexed in Scilit:
- Combined ERCP and EUS in One Session Is Safe in Elderly Patients When Compared to Non-elderly Patients: Outcomes in 206 Combined ProceduresDigestive Diseases and Sciences, 2012
- Complications of ERCPGastrointestinal Endoscopy, 2012
- Precut sphincterotomy, repeated cannulation and post-ERCP pancreatitis in patients with bile duct stone diseaseDigestive and Liver Disease, 2011
- ERCP in the Very Elderly: Outcomes Among Patients Older than EightyDigestive Diseases and Sciences, 2009
- Polypharmacy in elderly patientsThe American Journal of Geriatric Pharmacotherapy, 2007
- Outcome of ERCP in the Management of Duct-to-Duct Anastomotic Strictures in Orthotopic Liver TransplantDigestive Diseases and Sciences, 2007
- ERCP is safe and effective in patients 80 years of age and older compared with younger patientsGastrointestinal Endoscopy, 2006
- Postoperative management of noniatrogenic traumatic bile duct injuries: role of endoscopic retrograde cholangiopancreaticographySurgical Endoscopy, 2006
- Efficacy and safety of therapeutic ERCP in patients 90 years of age and olderGastrointestinal Endoscopy, 2006
- Duodenoscopic sphincterotomy in the treatment of the ?sump syndrome?Digestive Diseases and Sciences, 1981